Proceedings of the Fourth World Congress of Anes-
thesiologists. Amsterdam, Excerpta Medica, Interna-
tional Congress Series 200, 1968, pp 394-399.
34. Eger EI II, Smith NT, Stoelting RK, et al: Cardiovas-
cular effects of halothane in man. Anesthesiology
32:396–409, 1970.
35. Gibbons RT, Steffey EP, Eger EI II: The effect of spon-
taneous versus controlled ventilation on the rate of
rise of alveolar halothane concentration in dogs.
Anesth Analg 56:32–34, 1977.
36. Eger EI II, Bahlman SH, Munson ES: Effect of age on
the rate of increase of alveolar anesthetic concentra-
tion. Anesthesiology 35:365–372, 1971.
37. Wahrenbrock EA,Eger EI II,Laravuso RB,Maruschak
G:Anesthetic uptake—of mice and men (and whales).
Anesthesiology 40:19–23, 1974.
38. Munson ES,Eger EI II,ThamMK,EmbroWJ: Increase
in anesthetic uptake, excretion and blood solubility in
man after eating. Anesth Analg 57:2221–2231, 1978.
39. Gallagher TM, Black GW: Uptake of volatile anaes-
thetics in children. Anaesthesia 40:1073–1077, 1985.
40. Eger EI II,Severinghaus JW:Effect of uneven pulmonary
distribution of blood and gas on induction with inhala-
tion anesthetics.Anesthesiology 25:620–626, 1964.
41. Stoelting RK, Longnecker DE: Effect of right-to-left
shunt on rate of increase in arterial anesthetic con-
centration. Anesthesiology 36:352–356, 1972.
42. Eger EI II, Saidman LJ: Hazards of nitrous oxide anes-
thesia in bowel obstruction and pneumothorax.Anes-
thesiology 26:61–66, 1965.
43. Hunter AR: Problems of anaesthesia in artificial
pneumothorax. Proc R Soc Med 48:765, 1955.
44. Munson ES, Merrick HC: Effect of nitrous oxide on
venous air embolism. Anesthesiology 27:783–787,
1966.
45. Shapiro HM, Yoachim J, Marshall LF: Nitrous oxide
challenge for detection of residual intravascular pul-
monary gas following venous air embolism. Anesth
Analg 61:3021–3026, 1982.
46. Stanley TH, Kawamura R, Graves C: Effects of nitrous
oxide on volume and pressure of endotracheal tube
cuffs. Anesthesiology 41:256–262, 1974.
47. Kaplan R,Abramowitz MD, Epstein BS: Nitrous oxide
and air-filled balloon-tipped catheters. Anesthesio-
logy 55:71–73, 1981.
48.Algren JT, Gursoy F, Johnson TD, Skjonsby BS: The effect
of nitrous oxide diffusion on laryngeal mask airway cuff
inflation in children. Paediatr Anaesth 8:31–36, 1998.
49. Wolf GL,Capuano C,Hartung J: Nitrous oxide increa-
ses intraocular pressure after intravitreal sulfur hexa-
fluoride injection. Anesthesiology 59:547–548, 1983.
50. Thomsen KA, Terkildsen K, Arnfred J: Middle ear
pressure variations during anesthesia.Arch Otolaryn-
gol 82:609–611, 1985.
51. Saidman LJ, Eger EI II: Change in cerebrospinal fluid
pressureduringpneumoencephalographyundernitrous
oxide anesthesia. Anesthesiology 26:67–72, 1965.
52. Waun JE,Sweitzer RS,HamiltonWK: Effect of nitrous
oxide on middle ear mechanics and hearing acuity.
Anesthesiology 28:846–850, 1987.
53. GrahamMD, Knight PR: Atelectative tympanic mem-
brane reversal by nitrous oxide supplemented general
anesthesia and polyethylene ventilation tube inser-
tion. A preliminary report. Laryngoscope 41:1469,
1981.
54. Eger EI II, Ionescu P, Gong D: Circuit absorption of
halothane, isoflurane and sevoflurane. Anesth Analg
86:1070–1074, 1998.
55. Targ AG, Yasuda N, Eger EI II: Solubility of I-653,
sevoflurane, isoflurane, and halothane in plastics and
rubber composing a conventional anesthetic circuit.
Anesth Analg 68:218–225, 1989.
56. Strum DP, Johnson BH, Eger EI II: Stability of sevo-
flurane in soda lime. Anesthesiology 67:779–781,
1987.
57. Higuchi H, Sumita S, Wada H, et al: Effects of sevo-
flurane and isoflurane on renal function and on pos-
sible markers of nephrotoxicity. Anesthesiology
89:307–322, 1998.
58. Eger EI II, Gong D, Koblin DD, et al: Dose-related
biochemical markers of renal injury after sevoflurane
vs. desflurane anesthesia in volunteers. Anesth Analg
85:1154–1163, 1997.
59. Kobayashi S, Bito H, Obata Y, et al: Compound A
concentration in the circle absorber system during
low-flow sevoflurane anesthesia: Comparison of Dra-
gersorb Free, Amsorb, and Sodasorb II. J Clin Anesth
15:33–37, 2003.
60. Fang ZX,Eger EI II,Laster MJ,et al: Carbon monoxide
production from degradation of desflurane, enflu-
rane, isoflurane, halothane, and sevoflurane by soda
lime and Baralyme. Anesth Analg 80:1187–1193,
1995.
61. Knolle E, Heinze G, Gilly H: Small carbon monoxide
formation in absorbents does not correlate with small
carbon dioxide absorption.Anesth Analg 95:650–655,
2002.
62. Harper M, Eger EI II: A comparison of the efficiency
of three anesthesia circle systems. Anesth Analg
55:7221–7229, 1976.
63. Severinghaus JW: The rate of uptake of nitrous oxide
in man. J Clin Invest 33:1183–1189, 1954.
64. Lowe HJ, Ernst EA: The Quantitative Practice of
Anesthesia:Useof Closed Circuit.Baltimore,Williams
& Wilkins, 1981.
65. Hendrickx JFA, Soetens M, VanderDonck A, et al:
Uptake of desflurane and isoflurane during closed-
circuit anesthesia with spontaneous and controlled
mechanical ventilation. Anesth Analg 84:413–418,
1997.
66. Eger EI II: Complexities overlooked: Things may not
be what they seem. Anesth Analg 84:239–240, 1997.
67. Eger EI II: Desflurane (Suprane):A Compendium and
Reference. Rutherford, NJ, Healthpress Publishing,
1993, pp 1–119.
68. Weiskopf RB, Eger EI II: Comparing the costs of
inhaled anesthetics. Anesthesiology 79:1413–1418,
1993.
69. Eger EI II, Johnson BH: Rates of awakening from
anesthesia with I-653,halothane, isoflurane,and sevo-
flurane:A test of the effect of anesthetic concentration
and duration in rats. Anesth Analg 66:977–982,
1987.
70. Mapleson WW: Quantitative prediction of anesthetic
concentrations.
In
Papper EM, Kitz RJ (eds): Uptake
and Distribution of Anesthetic Agents. New York,
McGraw-Hill, 1963, pp 1021–1119.
71. Stoelting RK, Eger EIII: The effects of ventilation
and anesthetic solubility on recovery from anes-
thesia: An in vivo and analog analysis before and
after equilibration. Anesthesiology 30:290–296,
1969.
72. Nordmann GR, Read JA, Sale SM, et al: Emergence
and recovery in children after desflurane and isoflu-
rane anaesthesia: Effect of anaesthetic duration. Br J
Anaesth 96:779–785, 2006.
73. Eger EI Jr, Gong D, Koblin DD, et al: Effect of
anesthetic duration on kinetic and recovery cha-
racteristics of desflurane vs. sevoflurane (plus
compound A) in volunteers. Anesth Analg 86:414–
421, 1998.
74. Bailey JM: Context-sensitive half-times and other
decrement times of inhaled anesthetics.Anesth Analg
85:681–686, 1997.
75. Eger EI II, Shafer SL: Tutorial: Context-sensitive
decrement times for inhaled anesthetics. Anesth
Analg 101:688–696, 2005.
76. Sundman E, Witt H, Sandin R, et al: Pharyngeal
function and airway protection during subhypnotic
concentrations of propofol, isoflurane, and sevoflu-
rane.Volunteers examined by pharyngeal videoradio-
graphy and simultaneous manometry.Anesthesiology
95:1125–1132, 2001.
77. McKay RE,Large MJC,Balea MC
,McKayWR:Airwayreflexes return more rapidly after desflurane anesthe-
sia than after sevoflurane anesthesia. Anesth Analg
100:697–700, 2005.
78. Katoh T, Suguro Y, Nakajima R, et al: Blood concen-
tration of sevoflurane and isoflurane on recovery
from anaesthesia. Br J Anaesth 69:259–262, 1992.
79. Dwyer R, Bennett HL, Eger EI II, Heilbron D: Effects
of isoflurane and nitrous oxide in subanesthetic con-
centrations on memory and responsiveness in volun-
teers. Anesthesiology 77:888–898, 1992.
80. Katoh T, Suguro Y, Ikeda T, et al: Influence of age on
awakening concentrations of sevoflurane and isoflu-
rane. Anesth Analg 76:348–352, 1993.
81. Chortkoff BS, Eger EI II, Crankshaw DP, et al: Con-
centrations of desflurane and propofol that suppress
response to command in humans. Anesth Analg
81:737–743, 1995.
82. Neumann MA, Weiskopf RB, Gong DH, et al: Chan-
ging from isoflurane to desflurane towards the end of
anesthesia does not accelerate recovery in humans.
Anesthesiology 88:914–921, 1998.
83. Fink BR: Diffusion anoxia. Anesthesiology 16:511–
519, 1955.
84. Rackow H, Salanitre E, Frumin MJ: Dilution of alveo-
lar gases during nitrous oxide excretion in man.J Appl
Physiol 16:723–728, 1961.
Anestésicos inhalatorios: captación y distribución
325
11
Sección II
Farmacología y anestesia
© ELSEVIER. Fotocopiar sin autorización es un delito